Top 10 Companies in the Docosahexaenoic Acid DHA Thraustochytrid Algae Marine PUFA Market (2026): Market Leaders Powering Global Omega‑3 Supply

MARKET INSIGHTS

Global Docosahexaenoic Acid DHA Thraustochytrid Algae Marine PUFA Market size was valued at USD 1.80 billion in 2025. The market is projected to grow from USD 1.98 billion in 2026 to USD 4.20 billion by 2034, exhibiting a CAGR of 9.8% during the forecast period.

Docosahexaenoic Acid (DHA) from thraustochytrid algae represents a key category within marine‑derived polyunsaturated fatty acids (PUFAs). These specialized microorganisms, such as Schizochytrium and related strains, serve as sustainable, heterotrophic sources of high‑purity DHA omega‑3, cultivated through advanced fermentation processes rather than traditional fish oil extraction. This algal route delivers concentrated DHA without the environmental pressures associated with marine fisheries while offering superior purity and consistency for end‑use applications.

The market is experiencing strong expansion driven by rising consumer demand for plant‑based and sustainable omega‑3 sources, increasing applications in infant nutrition, dietary supplements, and functional foods, alongside growing awareness of DHA’s critical role in brain development, cognitive health, and cardiovascular wellness. Regulatory support for DHA fortification in infant formulas and clinical nutrition further accelerates adoption. Advancements in strain optimization and fermentation technologies have enhanced production efficiency, enabling thraustochytrid‑derived DHA to capture significant share in the broader algae omega‑3 segment. Major industry participants continue to invest in capacity expansion and innovation to meet the evolving needs of health‑conscious consumers and formulators seeking clean‑label, vegan‑friendly ingredients.

Docosahexaenoic Acid DHA Thraustochytrid Algae Marine PUFA Market – View in Detailed Research Report

1. dsm‑firmenich (life’sDHA / Veramaris)

Headquarters: Netherlands/Switzerland
Key Offering: High‑purity algal DHA oils for human nutrition and aquafeed applications

dsm‑firmenich, through its life’sDHA portfolio and the Veramaris joint venture with Evonik, has become the global leader in thraustochytrid‑derived DHA. Leveraging proprietary Schizochytrium strains and large‑scale fermentation, the company delivers clean‑label, vegan‑friendly DHA that meets stringent regulatory approvals worldwide.

Sustainability & Growth Initiatives:

• Integrated biorefinery model to co‑produce squalene and carotenoids, enhancing circular economy credentials.
• Expansion of fermentation capacity by 30% to meet rising demand in infant nutrition and dietary supplements.
• Investment in strain optimization to increase DHA content to 70% of total lipids.

2. Corbion (AlgaPrime DHA)

Headquarters: Netherlands
Key Offering: AlgaPrime™ DHA oil for aquafeed and nutraceutical markets

Corbion’s AlgaPrime™ DHA is a premium algal oil used extensively in salmon diets and infant formulas. The company’s focus on high‑purity, fish‑free DHA aligns with global sustainability trends and regulatory frameworks.

Sustainability & Growth Initiatives:

• Partnerships with aquaculture producers to optimize DHA inclusion rates.
• Use of low‑cost, waste‑derived carbon sources to reduce production costs.
• Continuous improvement of downstream processing to enhance purity and shelf life.

3. Mara Renewables Corporation

Headquarters: Canada
Key Offering: Sustainable thraustochytrid DHA for infant nutrition and functional foods

Mara Renewables focuses on advanced fermentation of Schizochytrium strains, producing high‑purity DHA with lower environmental impact. The company is expanding its global footprint through strategic alliances.

Sustainability & Growth Initiatives:

• Co‑development of biorefinery concepts to extract high‑value carotenoids.
• Collaboration with Canadian aquaculture farms to pilot DHA‑enriched feeds.
• Investment in digital traceability platforms for supply chain transparency.

4. Fermentalg

Headquarters: France
Key Offering: Tailored thraustochytrid strains for high‑yield DHA production

Fermentalg’s proprietary strains achieve up to 70% DHA content, positioning the company as a key supplier for nutraceutical and pharmaceutical applications.

Sustainability & Growth Initiatives:

• Utilization of agro‑industrial by‑products as carbon sources.
• Scaling of fermentation facilities to meet global demand.
• Research into EPA‑enriched strains for balanced omega‑3 profiles.

5. Lonza Group

Headquarters: Switzerland
Key Offering: GMP‑grade DHA oils for clinical nutrition and functional foods

Lonza’s advanced fermentation platform supports high‑purity DHA production with rigorous quality control, catering to the clinical nutrition sector.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient bioreactors.
• Partnerships with European nutraceutical firms to expand product reach.
• Commitment to reduce water consumption in fermentation processes.

6. CABIO Biotech

Headquarters: China
Key Offering: Scalable thraustochytrid DHA production for Asian markets

With a focus on cost‑competitiveness, CABIO Biotech leverages local feedstock and optimized fermentation to supply DHA to the rapidly growing Asian nutraceutical market.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources in production facilities.
• Integration of waste‑water treatment systems.
• Expansion of product portfolio to include high‑concentration DHA concentrates.

7. Xiamen Huison Biotech Co., Ltd.

Headquarters: China
Key Offering: Customized DHA formulations for infant nutrition and dietary supplements

Xiamen Huison focuses on delivering traceable, high‑purity DHA oils with stringent quality standards suitable for infant formulas and functional foods.

Sustainability & Growth Initiatives:

• Development of closed‑loop fermentation systems.
• Collaboration with Chinese regulatory bodies for expedited approvals.
• Investment in R&D for EPA‑enriched thraustochytrid strains.

8. Guangdong Runke Bioengineering Co., Ltd.

Headquarters: China
Key Offering: High‑purity DHA oils for aquafeed and nutraceutical markets

Runke Bioengineering combines advanced fermentation with downstream purification to deliver premium DHA products for global markets.

Sustainability & Growth Initiatives:

• Utilization of industrial by‑products as low‑cost substrates.
• Implementation of energy‑saving technologies in bioreactors.
• Expansion of production capacity to meet Asian demand.

9. HSF Biotech

Headquarters: China
Key Offering: Sustainable thraustochytrid DHA for functional foods and beverages

HSF Biotech’s DHA oils are tailored for beverage applications, offering stability and clean‑label attributes.

Sustainability & Growth Initiatives:

• Development of microencapsulated DHA powders for easy incorporation.
• Partnerships with beverage manufacturers for pilot projects.
• Focus on reducing carbon footprint through process optimization.

10. Biorigin

Headquarters: United Kingdom
Key Offering: Advanced DHA isolates for pharmaceutical and nutraceutical applications

Biorigin specializes in high‑purity, pharmaceutical‑grade DHA, supporting clinical research and high‑value nutraceutical products.

Sustainability & Growth Initiatives:

• Investment in GMP‑compliant manufacturing facilities.
• Collaboration with global health organizations for clinical trials.
• Adoption of circular economy practices in raw material sourcing.

Download FREE Sample Report: Docosahexaenoic Acid DHA Thraustochytrid Algae Marine PUFA Market – View in Detailed Research Report

Get Full Report Here: Docosahexaenoic Acid DHA Thraustochytrid Algae Marine PUFA Market – View in Detailed Research Report

Outlook: The Future of Docosahexaenoic Acid DHA Thraustochytrid Algae Marine PUFA Market

The Docosahexaenoic Acid DHA market is poised for sustained growth, driven by continued consumer shift towards plant‑based, sustainable omega‑3 sources and regulatory support for DHA fortification across infant nutrition and clinical nutrition.

Key Trends Shaping the Market:

• Microbial strain engineering to achieve higher DHA yields and balanced EPA/DHA profiles.
• Expansion of integrated biorefineries co‑producing high‑value by‑products such as squalene and carotenoids.
• Adoption of circular economy practices using agro‑industrial waste as fermentation substrates.
• Increasing demand for clean‑label, microencapsulated DHA powders in functional foods and beverages.
• Growing focus on regulatory compliance and traceability in emerging markets.

Future Trends

Emerging trends include the development of personalized nutrition solutions leveraging DHA‑enriched algae oils, the integration of AI‑driven process optimization for fermentation, and the exploration of marine‑derived DHA for pharmaceutical applications targeting neurodegenerative diseases.